When you need to meet your timeline without sacrificing quality, you need a CRO who puts you first. Choose a project management partner that will prioritize your project as much as you do. Download our fact sheet to learn more.
De novo assay development holds great promise for future drug discovery projects, potentially reducing costs, improving success rates, and ultimately benefiting patients by accelerating the development of safe and effective therapeutics. Download our white paper to learn what you need to know with regard to new biomarker assay development.
As your dedicated partner with extensive protein chemistry expertise, the Prolytix approach transcends conventional methods. Protein concentration measurements are fundamental for many types of experiments. We use SoloVPE to accurately measure protein concentration at an exceptional rate, ensuring that your experiment is off to the right start. Download our fact sheet to learn more.
In this white paper, discover enhanced polysorbate analysis with mixed-mode HPLC. Download now.
Realizing the therapies of the future requires ongoing innovation and measurable advancements in biotherapeutic development. In this blog, we look at three essential ways that this is currently being achieved: A commitment to the highest levels of excellence in science, as well as prioritizing collaboration between our scientists and the clients that come to Prolytix …
Top Factors Driving Advancements in Biotherapeutic Development Read More »
Choosing the right bioanalytical CRO partner is one of the most important decisions you’ll make in the development of your drug. For comprehensive characterization that enables you to make your biggest decisions with confidence, go with the pro — Prolytix. Download Now:
Picking a partner for your biotherapeutic program is one of the most crucial decisions you’ll make. When you partner with a CRO, you’re melding outside expertise and resources with your internal knowledge base to expand and accelerate your problem-solving capabilities. This is a tremendous gain, but it’s important to remember that you are the client, …
Choosing the appropriate analytical and bioanalytical CRO partner is critical to the success of your biotherapeutic drug development program. Selecting the wrong partner could delay timelines and increase costs, putting your innovation at risk. For large molecule and protein chemistry expertise to accelerate your drug development, go with the pro — Prolytix. Download Now:
Explore our work with a highly efficient method of plasma fractionation that could revolutionize IVIG production in this process talk by Matthew Whelihan, Ph.D. Download Now:
Using mass spectrometry to identify and quantify HCPs enables a more rational development of robust purification processes.
